Futuristic Senolytic Drug Incorporated Nanomedicine Therapy to Treat Osteoarthritis
Nanomedicine · 2024
DOI: 10.2217/nnm-2023-0348 ↗Kurz gefasst
Editorial in der Zeitschrift Nanomedicine, 2024. Verfasst von Laxmi Akhileshwar Jha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Naraina Vidya Peeth Group of Institutions, Faculty of Pharmacy, Dr. A. P. J. Abdul Kalam Technical University, Kanpur, 0208020, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Senotherapeutics, Osteoarthritis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Naraina Vidya Peeth Group of Institutions, Faculty of Pharmacy, Dr. A. P. J. Abdul Kalam Technical University, Kanpur, 0208020, Uttar Pradesh, India.
- Department of Biological Sciences & Bioengineering (BSBE), Indian Institute of Technology, Kanpur, 208016, Uttar Pradesh, India.
- Centre for Inflammation, Centenary Institute & University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW, 2007, Australia.
ORCID-Profile: Laxmi Akhileshwar Jha, Bhupendra Kumar, Saurav Kumar Jha, Keshav Raj Paudel
Zitieren
APA
Jha, L. A., Kumar, B., Jha, S. K., & Paudel, K. R. (2024). Futuristic Senolytic Drug Incorporated Nanomedicine Therapy to Treat Osteoarthritis. Nanomedicine. https://doi.org/10.2217/nnm-2023-0348
Vancouver
Jha LA, Kumar B, Jha SK, Paudel KR. Futuristic Senolytic Drug Incorporated Nanomedicine Therapy to Treat Osteoarthritis. Nanomedicine. 2024. doi:10.2217/nnm-2023-0348
BibTeX
@article{Jha2024,
author = {Jha, Laxmi Akhileshwar and Kumar, Bhupendra and Jha, Saurav Kumar and Paudel, Keshav Raj},
title = {Futuristic Senolytic Drug Incorporated Nanomedicine Therapy to Treat Osteoarthritis},
journal = {Nanomedicine},
year = {2024},
doi = {10.2217/nnm-2023-0348}
}
EUVIMED